Content about Biovail

February 8, 2011

Valeant Pharmaceuticals subsidiary Biovail Labs International has licensed Canadian rights to a treatment for acne from Allergan, Valeant said Tuesday.

MISSISSAUGA, Ontario — Valeant Pharmaceuticals subsidiary Biovail Labs International has licensed Canadian rights to a treatment for acne from Allergan, Valeant said Tuesday.

Under the terms of the agreement concerning the drug Aczone (dapsone) gel in the 5% strength, Biovail will pay Allergan about $500,000 Canadian dollars (about $504,693) upfront, as well as payments based on net sales.

February 3, 2011

Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores.

MISSISSAUGA, Ontario — Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores.

Valeant announced Thursday that it had acquired the rights to nonophthalmic topical formulations of Zovirax (acyclovir) from GSK for $300 million through its Canadian subsidiary, Biovail Labs.

October 31, 2010

Valeant Pharmaceuticals International's subsidiary Biovail Labs International has agreed to acquire several privately owned skin...

September 27, 2010

The merger between Valeant Pharmaceuticals International and Biovail is complete, the two companies said Tuesday....

MISSISSAUGA, Ontario The merger between Valeant Pharmaceuticals International and Biovail is complete, the two companies said Tuesday.

 

Shareholders of both companies have approved the merger, worth more than $3 billion, originally announced in June.

 

 

The combined company will take Valeant’s name.

 

June 20, 2010

U.S. drug maker Valeant and Canadian drug maker Biovail will merge, the two companies said...

March 15, 2010

The Food and Drug Administration has approved a Watson Pharmaceuticals drug for hypertension, Watson announced...

February 20, 2010

Watson Pharmaceuticals has filed a regulatory approval application with the Food and Drug Administration for...

February 9, 2010

An inhaled mental health drug could appear on the market in the near future under...